This document summarizes a study that evaluated different treatment methods for dysfunctional uterine bleeding based on endometrial thickness. 49 patients were divided into groups based on endometrial thickness and treated with combined oral contraceptive pills, conjugated estrogen plus progesterone, or megestrol. Results showed that treatments effectively decreased bleeding days and megestrol treatment resulted in endometrial hyperplasia in over 50% of patients. The study supports treating dysfunctional uterine bleeding according to endometrial thickness.

1. About Dovepress Contact Us Sustainability Press Releases Testimonials Favored Author Program Permissions Login
Search Dovepress Search
Home Browse Journals Why Publish with Dove? Editors-in-Chief Author Guidelines Peer Review Guidelines
Back to Dovepress Journal: International Journal of Women's Health
Management of dysfunctional uterine bleeding
based on endometrial thickness Interested in being a
peer-reviewer?
Click here to register.
(7850) Total Article Views
Other Testimonials
1 0 2 5 2 "You do a tremendous
Authors: Ozgul Muneyyirci-Delale, Anuja Gupta, Cynthia Abraham, et al. job!!" Ruben Restrepo, The
Published Date September 2010 Volume 2 0 1 0 : 2 Pages 297 - 3 0 2 University of Texas Health
DOI: http://dx.doi.org/10.2147/IJWH.S11531 Science Center at San
International Journal of Antonio
Women's Health
Ozgul Muneyyirci-Delale1,2, Anuja Gupta1,2, Cynthia Abraham1 , Ashadeep Chandrareddy1 , Most Viewed Papers
Journal Homepage Charles H Bowers Jr2 , Jed B Cutler2
Contraceptive practices in
Editor-in-Chief Nigeria: Literature review
1 2
Honorary Editorial Board Departments of Obstetrics and Gynecology, SUNY Downstate Medical Center, Kings
and recommendation for
County Hospital Center, Brooklyn, New York, USA
Author Fees future policy decisions
Article Archive
Objective: To manage patients with dysfunctional uterine bleeding (DUB) according to Tinidazole in the treatment
2012 Volume 4
endometrial thickness. of bacterial vaginosis
2011 Volume 3
2010 Volume 2
Methods: A retrospective chart review of 49 patients who reported 8 or more days of Diagnosis and management
2009 Volume 1
bleeding was performed. They were then divided into three groups based on endometrial of pre-eclampsia: an
thickness (mm): less than 6, 6–11, and greater than 11. These three groups were treated update
About Dovepress with combined oral contraceptive pills (OCP), conjugated estrogen plus progesterone and
Open access peer- megestrol respectively. Patients given megestrol also underwent endometrial biopsy Treating dyspareunia
reviewed scientific and before treatment. Patients recorded the degree of bleeding each day for one month after caused by vaginal atrophy:
medical journals. a review of treatment
starting treatment.
options using vaginal
Open Access Results: Mean endometrial thickness in the combined OCPs, conjugated estrogen plus estrogen therapy
Dove Medical Press is now progesterone and megestrol groups were 4, 8 and 14 mm, respectively. Combined OCPs
a member of the Open
decreased bleeding from 46 to 8 days (P < 0.05, n = 8). Conjugated estrogen plus Do you participate
Access Initiative
progesterone decreased the number of days of bleeding from a mean of 41 to 9 (P < 0.01, in Blogs?
n = 16). Megestrol decreased bleeding from 54 to 3 days (P < 0.001, n = 25). 52% of
An Author's Guide c
d
e
f
g Read
patients given megestrol had endometrial hyperplasia.
A guide to help authors get c
d
e
f
g Comment on
their paper published. c
d
e
f
g Write for
Conclusion: These results support the effectiveness of treating patients with DUB
according to endometrial thickness. c
d
e
f
g None of the above
Advocacy
Support Open Access and
Dove Press
Keywords: DUB, abnormal uterine bleeding, endometrium, hyperplasia, megestrol acetate
Vote
Reprints
View Results
Promotional Article
Monitoring - further details
Favored Author
Post to:
Program Cannotea Citeulike Del.icio.us Facebook LinkedIn Twitter
Real benefits for authors,
including fast-track
processing of papers.
Other articles by Dr Ozgul Muneyyirci-Delale
Medical management of recurrent endometrioma with long-term norethindrone acetate
Readers of this article also read:
Safety, efficacy and patient acceptability of the contraceptive and non-contraceptive uses of the
LNG-IUS
Raising HDL cholesterol in women
Efficacy and safety of combined ethinyl estradiol/drospirenone oral contraceptives in the treatment
of acne
The lowest-dose, extended-cycle combined oral contraceptive pill with continuous ethinyl estradiol
in the United States: a review of the literature on ethinyl estradiol 20 µg/levonorgestrel 100 µg +
ethinyl estradiol 10 µg
Sexually transmitted infections among Pakistani pregnant women and their husbands in Norway
Diagnosis and management of pre-eclampsia: an update
Transvaginal sonographic evaluation at different menstrual cycle phases in diagnosis of uterine
lesions
Treatment options for vasomotor symptoms in menopause: focus on desvenlafaxine
Uterine prolapse prevention in Eastern Nepal: the perspectives of women and health care
professionals
A molar masquerading as an ectopic pregnancy in the early first trimester: a salutary lesson

2. Search for more articles in the Dovepress Journal: International Journal of Women's Health
Favored Author Program Award Nominations Open Call For Submissions About Dovepress
We offer real benefits to our authors, Submit Original Research Article, Dove Medical Press Ltd is a privately
including fast-track processing of Review, Case Report, or Rapid held company specializing in the
papers. Communication in International publication of Open Access peer-
Journal of Women's Health reviewed journals across the broad
spectrum
Contact Us Privacy Policy Associations & Partners Testimonials Sitemap Terms and Conditions Recommend this site
Copyright© 2 0 1 2 Dove Medical Press Ltd, All Rights Reserved.
The opinions expressed in all articles published here are those of the specific author(s), and do not necessarily reflect the views of Dove Medical Press Ltd or any of its employees.